Kali Muriaticum Tablet
FDA Label NDC 54973-5224

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hyland's Inc. for the product Kali Muriaticum (NDC 54973-5224). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding directions, otc - purpose, formula, inactive ingredient, otc - do not use, otc - ask doctor/pharmacist, otc - stop use, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Do Not Use

Do not use if imprinted cap band is broken or missing.

Do not use more than 2 days or administer to children under three years of age unless directed by physician.

Otc - Ask Doctor/Pharmacist

If symptoms persist for more than seven days or worsen, contact a licensed health care provider.

Otc - Stop Use

Discontinue use if symptoms are accompanied by a high fever (over 101° F). Severe or persistent sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult physician promptly.

Otc - Pregnancy Or Breast Feeding

If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product.

Otc - Keep Out Of Reach Of Children

Keep this and all medications out of the reach of children.

* Please review the disclaimer below.